Seres Therapeutics, Inc.
Industry: Life Sciences ・ $MCRB on Nasdaq
Insider Sale
+$2,749
-4.99%
Shares
Shares Volume: 3,984 Shares
Average Share Price: $0.69
INSIDER
Henn Matthew R.
See Remarks (Officer)
reported on Oct 29 2024
traded on Oct 27 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 75,885 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $2,216.36 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 29 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $4,033.24 |
| COMPANY PREVIOUS TRADES |